A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: customized (34), tailored (76), adapted (132), personalized (74), bespoke (38), custom-made (3)

Annual-report-24-25-final

Description
2024/25 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2024/25 Presented to Parliament
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-24-25-final.pdf

Annual-report-2018-19

Description
ANNUAL REPORT AND ACCOUNTS 2018/19 incorporating the quality account 2018/19 Presented to Parliament pursuant to Schedule 7, paragraph 25
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2018-19.pdf

Annual report 20-21

Description
2020/21 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2020/21 Pres
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-20-21.pdf

Press release: Southampton researchers secure £3 million for dedicated infection lab

Description
Clinicians and researchers in Southampton have secured £2.8 million to develop cutting-edge research laboratories to tackle antibiotic-resistant infections
Url
/AboutTheTrust/Newsandpublications/Latestnews/2019/June/Press-release-Southampton-researchers-secure-3-million-for-dedicated-infection-lab.aspx

Press release - Southampton doctors in world-first trial of new nose drop to fight meningitis

Description
Doctors in Southampton are leading a world-first trial of a new nose drop that could help prevent meningitis and other
Url
/AboutTheTrust/Newsandpublications/Latestnews/2018/November-2018/Press-release-Southampton-doctors-in-world-first-trial-of-new-nose-drop-to-fight-meningitis.aspx

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

SOP validation favourite agents Aria ver1

Description
Central South Coast Cancer Network Standard Operating Procedure Validation of CSCCN Favourite Agents in Aria (SOP:CH006) 1. Objective 1.1
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/SOPvalidationfavouriteagentsAriaver1.pdf

SOP validation dose banding Aria ver1

Description
Central South Coast Cancer Network Standard Operating Procedure Validation of CSCCN Dose Banding in Aria (SOP:CH004) 1. Objective 1.1
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/SOPvalidationdosebandingAriaver1.pdf

Prof Robert Read, theme lead for microbial science

Description
NIHR Southampton Biomedical Research Centre Auto Generated Title Combining clinical and research expertise, Professor Read is Director-design
Url
/ClinicalResearchinSouthampton/Our-people/Microbial-science-people/Prof-Robert-Read-theme-lead-for-microbial-science.aspx

Prof Robert Read, director NIHR Southampton Biomedical Research Centre

Description
NIHR Southampton Biomedical Research Centre Auto Generated Title Professor Read is director of the NIHR Southampton Biomedical Research Centr
Url
/ClinicalResearchinSouthampton/Our-people/Directors/Prof-Robert-Read-director-NIHR-Southampton-Biomedical-Research-Centre.aspx
41 to 50 of 121
Previous … 3 4 5 6 7 … Next